Generics in Canada, MarketLine

  • August 2013
  • -
  • MarketLine
  • -
  • 34 pages

Introduction

Generics in Canada industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2008-12, and forecast to 2017). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Canada generics market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Highlights

*For the purposes of this profile, a generic is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and all branded generics are included. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included.

*The Canadian generics market had total revenues of $5.4bn in 2012, representing a compound annual growth rate (CAGR) of 6.6% between 2008 and 2012.

*Market consumption volume increased with a CAGR of 5.2% between 2008-2012, to reach a total of 60.1% of total pharma volume in 2012.

*The performance of the market is forecast to decelerate, with an anticipated CAGR of 4.2% for the five-year period 2012 - 2017, which is expected to drive the market to a value of $6.7bn by the end of 2017.

Features

Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the generics market in Canada

Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the generics market in Canada

Leading company profiles reveal details of key generics market players’ global operations and financial performance

Add weight to presentations and pitches by understanding the future growth prospects of the Canada generics market with five year forecasts by both value and volume

Macroeconomic indicators provide insight into general trends within the Canada economy

Key Questions Answered

What was the size of the Canada generics market by value in 2012?

What will be the size of the Canada generics market in 2017?

What factors are affecting the strength of competition in the Canada generics market?

How has the market performed over the last five years?

What are the main segments that make up Canada's generics market?

Table Of Contents

Generics in Canada, MarketLine
TABLE OF CONTENTS
Executive Summary 2
Market value 2
Market value forecast 2
Market volume 2
Market volume forecast 2
Geography segmentation 2
Market rivalry 2
Market Overview 7
Market definition 7
Market analysis 7
Market Data 9
Market value 9
Market volume 10
Market Segmentation 11
Geography segmentation 11
Market Outlook 12
Market value forecast 12
Market volume forecast 13
Five Forces Analysis 14
Summary 14
Buyer power 16
Supplier power 17
New entrants 18
Threat of substitutes 19
Degree of rivalry 20
Leading Companies 21
Apotex, Inc. 21
Mylan Inc. 22
Sandoz International GmbH 25
Teva Pharmaceutical Industries Limited 26
Macroeconomic Indicators 30
Country Data 30
Appendix 32
Methodology 32
Industry associations 33
Related MarketLine research 33

LIST OF TABLES
Table 1: Canada generics market value: $ million, 2008-12 9
Table 2: Canada generics market volume: % of total pharma volume, 2008-12 10
Table 3: Canada generics market geography segmentation: $ million, 2012 11
Table 4: Canada generics market value forecast: $ million, 2012-17 12
Table 5: Canada generics market volume forecast: % of total pharma volume, 2012-17 13
Table 6: Apotex, Inc.: key facts 21
Table 7: Mylan Inc.: key facts 22
Table 8: Mylan Inc.: key financials ($) 22
Table 9: Mylan Inc.: key financial ratios 23
Table 10: Sandoz International GmbH: key facts 25
Table 11: Teva Pharmaceutical Industries Limited: key facts 26
Table 12: Teva Pharmaceutical Industries Limited: key financials ($) 27
Table 13: Teva Pharmaceutical Industries Limited: key financial ratios 28
Table 14: Canada size of population (million), 2008-12 30
Table 15: Canada gdp (constant 2000 prices, $ billion), 2008-12 30
Table 16: Canada gdp (current prices, $ billion), 2008-12 30
Table 17: Canada inflation, 2008-12 31
Table 18: Canada consumer price index (absolute), 2008-12 31
Table 19: Canada exchange rate, 2008-12 31

LIST OF FIGURES
Figure 1: Canada generics market value: $ million, 2008-12 9
Figure 2: Canada generics market volume: % of total pharma volume, 2008-12 10
Figure 3: Canada generics market geography segmentation: % share, by value, 2012 11
Figure 4: Canada generics market value forecast: $ million, 2012-17 12
Figure 5: Canada generics market volume forecast: % of total pharma volume, 2012-17 13
Figure 6: Forces driving competition in the generics market in Canada, 2012 14
Figure 7: Drivers of buyer power in the generics market in Canada, 2012 16
Figure 8: Drivers of supplier power in the generics market in Canada, 2012 17
Figure 9: Factors influencing the likelihood of new entrants in the generics market in Canada, 2012 18
Figure 10: Factors influencing the threat of substitutes in the generics market in Canada, 2012 19
Figure 11: Drivers of degree of rivalry in the generics market in Canada, 2012 20
Figure 12: Mylan Inc.: revenues and profitability 23
Figure 13: Mylan Inc.: assets and liabilities 24
Figure 14: Teva Pharmaceutical Industries Limited: revenues and profitability 28
Figure 15: Teva Pharmaceutical Industries Limited: assets and liabilities 29

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

Patent Cliff and the Future of Generics in Asia : Trends that will Impact the Market in the Short Term

Patent Cliff and the Future of Generics in Asia : Trends that will Impact the Market in the Short Term

  • $ 3 500
  • Industry report
  • December 2014
  • by Frost & Sullivan

Executive Summary •The generic drug manufacturers in Asia have started looking beyond patent cliff to drive growth. As less drugs are expected to go off patent in 2015–2017, the manufacturers are adopting ...

The Generic Drugs Market: 2015 – 2030 - Opportunities, Challenges, Strategies & Forecasts

The Generic Drugs Market: 2015 – 2030 - Opportunities, Challenges, Strategies & Forecasts

  • $ 2 500
  • Industry report
  • February 2015
  • by SNS Telecom

A generic drug is a pharmaceutical product, usually intended to be interchangeable with an innovator product, that is manufactured without a license from the innovator company and marketed after the expiry ...

Generics: Global Industry Guide

Generics: Global Industry Guide

  • $ 1 495
  • Industry report
  • December 2014
  • by MarketLine

Introduction Global Generics industry guide provides top-line qualitative and quantitative summary information including: market size (value and volume 2010-14, and forecast to 2019). The guide also contains ...

Generics In Japan, Marketline

December 2014 $ 350

Global Generics, Marketline

December 2014 $ 350

Generics In Belgium, Marketline

December 2014 $ 350

Generics In Canada, Marketline

December 2014 $ 350

Generics In Germany, Marketline

December 2014 $ 350

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.